February 16, 2021

Moderna Expects To Supply Second 100 Million Vaccine Doses To U.S. By May-End-Reuters

Moderna Inc said on Tuesday it was moving forward the supply target for the second 100 million of its COVID-19 vaccine doses to the United States by a month to May end. The biotech firm said short-term delays in the final stages of production and release of filled vials at Moderna’s fill and finish contractor Catalent Inc have recently delayed the release of some doses. Moderna said these delays are expected to be resolved in the near term and not expected to impact monthly delivery targets. Reuters, 02/16/2021